Clinical Trials Directory

Trials / Sponsors / Grupo Español de Investigación en Neurooncología

Grupo Español de Investigación en Neurooncología

Academic / Other · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingTuvusertib in Astrocytoma With ATRX Mutation
Astrocytoma
Phase 22025-12-19
CompletedTN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastom
Glioblastoma
Phase 1 / Phase 22023-08-18
CompletedGlasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
Glioblastoma
Phase 1 / Phase 22018-03-15
CompletedSafety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With
Oligodendroglioma, Oligoastrocytoma
Phase 22015-10-25
CompletedTemozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
Glioblastoma
Phase 22014-08-22
CompletedStudy to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glio
Glioblastoma Multiforme (Grade IV) of Cerebellum
Phase 12014-08-13
CompletedSafety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent G
Glioblastoma, Brain Tumor, Recurrent
Phase 22012-02-01
CompletedNeo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizu
Glioblastomas
Phase 22009-12-01
CompletedStudy of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
Glioblastoma
Phase 22009-06-01
UnknownMetronomic Temozolamide in Patients With Recurrent Glioblastoma
Glioblastoma
Phase 2 / Phase 32007-11-01